InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Gasser Elizabeth Anne, Vice-Présidente Exécutive, Directrice de la Stratégie. Director active across 2 companies, notably TANDEM DIABETES CARE INC. Aggregated, 13 reports have been published. The latest transaction was filed on 27 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
0373 shares0
Common Stock
SEC:0001438133-22-000145:0·
0650 shares0
Common Stock
SEC:0001438133-22-000073:0·
0372 shares0
Common Stock
SEC:0001438133-22-000023:0·
€63,018797 shares@ €79.06920.0072% mcap4.6% of flow
Common Stock
SEC:0001438133-21-000234·
€63,018797 shares@ €79.06920.0042% mcap4.6% of flow
Common Stock
SEC:0001438133-21-000234:0·
€63,228797 shares@ €79.33240.0072% mcap4.7% of flow
Common Stock
SEC:0001438133-21-000228·
€63,228797 shares@ €79.33240.0042% mcap4.7% of flow
Common Stock
SEC:0001438133-21-000228:0·
0373 shares0
Common Stock
SEC:0001438133-21-000218·
0373 shares0
Common Stock
SEC:0001438133-21-000218:0·
€1m15,936 shares@ €77.32670.14% mcap90.7% of flow
Common Stock
SEC:0001438133-21-000203·
€1m15,936 shares@ €77.32670.082% mcap90.7% of flow
Common Stock
SEC:0001438133-21-000203:0·
0372 shares0
Common Stock
SEC:0001438133-21-000149·
0372 shares0
Common Stock
SEC:0001438133-21-000149:0·
13 of 13 declarations
About Gasser Elizabeth Anne
Elizabeth Anne Gasser is the Executive Vice President and Chief Strategy Officer at Tandem Diabetes Care Inc. She oversees the company's strategic initiatives, aiming to strengthen its market position. Her expertise in strategy is essential for the organization's growth.
